These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 32769886

  • 1. Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.
    He Y, Xu R, Wang W, Zhang J, Hu X.
    Medicine (Baltimore); 2020 Aug 07; 99(32):e21502. PubMed ID: 32769886
    [Abstract] [Full Text] [Related]

  • 2. The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Wu Y, Li Y, Zheng Q, Li L.
    Nutrients; 2024 Jul 02; 16(13):. PubMed ID: 38999862
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol.
    Yang M, Yu Y, Lei PG, Yuan J.
    BMJ Open; 2019 Dec 02; 9(12):e027376. PubMed ID: 31796470
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
    Asha MZ, Khalil SFH.
    Sultan Qaboos Univ Med J; 2020 Feb 02; 20(1):e13-e24. PubMed ID: 32190365
    [Abstract] [Full Text] [Related]

  • 5. Acupoint application therapy for diarrhea-predominant irritable bowel syndrome: a protocol for systematic review and network meta-analysis.
    Yin X, Li S, Ouyang M, Ou R, Chen Z, Wei S, Huang H, Liu D.
    Ann Palliat Med; 2022 Dec 02; 11(12):3785-3793. PubMed ID: 36510459
    [Abstract] [Full Text] [Related]

  • 6. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.
    Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.
    Aliment Pharmacol Ther; 2018 Nov 02; 48(10):1044-1060. PubMed ID: 30294792
    [Abstract] [Full Text] [Related]

  • 7. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Wang M, Xie X, Zhao S, Ma X, Wang Z, Zhang Y.
    Front Immunol; 2023 Nov 02; 14():1136343. PubMed ID: 37275867
    [Abstract] [Full Text] [Related]

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA, Baffy N.
    Postgrad Med; 2017 Nov 01; 129(8):872-888. PubMed ID: 28936910
    [Abstract] [Full Text] [Related]

  • 10. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM, Whelan K.
    Proc Nutr Soc; 2016 Aug 01; 75(3):306-18. PubMed ID: 26908093
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E, Monaldi L, Ricci P, Fiorucci S.
    World J Gastroenterol; 2016 Feb 21; 22(7):2219-41. PubMed ID: 26900286
    [Abstract] [Full Text] [Related]

  • 13. Traditional Chinese medicine for irritable bowel syndrome: A protocol for meta-analysis.
    Yao CJ, Li YL, Pu MJ, Luo LH, Feng PM.
    Medicine (Baltimore); 2020 Nov 25; 99(48):e23394. PubMed ID: 33235116
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.
    Wang Y, Hu Y, Shi P.
    BMC Gastroenterol; 2024 Jul 05; 24(1):217. PubMed ID: 38970007
    [Abstract] [Full Text] [Related]

  • 15. Targeting the gut microbiota for the treatment of irritable bowel syndrome.
    Herndon CC, Wang YP, Lu CL.
    Kaohsiung J Med Sci; 2020 Mar 05; 36(3):160-170. PubMed ID: 31782606
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.
    Zhou S, Liu X, Wang X, Xi F, Luo X, Yao L, Tang H.
    Medicine (Baltimore); 2019 Jul 05; 98(30):e16446. PubMed ID: 31348246
    [Abstract] [Full Text] [Related]

  • 17. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials.
    Wilson B, Rossi M, Dimidi E, Whelan K.
    Am J Clin Nutr; 2019 Apr 01; 109(4):1098-1111. PubMed ID: 30949662
    [Abstract] [Full Text] [Related]

  • 18. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N, Li J, Wang Y, Zhang S.
    J Ethnopharmacol; 2023 Dec 05; 317():116672. PubMed ID: 37328079
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T, Mozaffari S, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2015 Mar 14; 21(10):3072-84. PubMed ID: 25780308
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P.
    Am J Gastroenterol; 2014 Oct 14; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.